Ludy van Beijsterveldt

Author

Also Known As

L Van Beijsterveldt, L. Van Beijsterveldt, L. van Beijsterveldt, Ludy Beijsterveldt, Ludy Van Beijsterveldt, Ludy van Beijsterveldt

Publications

799

Citations

H-Index

Concepts

All Affiliations

Janssen (Belgium)Johnson & Johnson (United States)Leiden University Johnson & Johnson (Brazil)

About

Ludy van Beijsterveldt is an author at Janssen (Belgium) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	335
2	Social Sciences	2	2	25
3	Biochemistry	2	2	108
4	Health Sciences	1	1	18
5	Natural Sciences	1	1	96

Ludy van Beijsterveldt

Publications

561

Citations

H-Index

Page 1

	Year	Citations
Intestinal uptake and biodistribution of novel polymeric micelles after oral administration Frédéric Mathot, Ludy van Beijsterveldt, Véronique Préat, Journal of Controlled Release Intestinal UptakeMedicineGastroenterologyMicelleOral Administration	2006	100
The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans Geert Mannens, Cor Snel, Jan Hendrickx, Drug Metabolism and Disposition	2002	97
Synthesis, Structure−Activity Relationship, and Receptor Pharmacology of a New Series of Quinoline Derivatives Acting as Selective, Noncompetitive mGlu1 Antagonists Dominique Mabire, Sophie Coupa, Christophe Adelinet, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryTranslational PharmacologyPotent Mglu1 AntagonistBiochemistry	2005	96
A Phase I First-in-Human Pharmacokinetic and Pharmacodynamic Study of Serdemetan in Patients with Advanced Solid Tumors Josep Tabernero, Luc Dirix, Patrick Schöffski, Clinical Cancer Research	2011	62
Tissue distribution and depletion kinetics of bortezomib and bortezomib-related radioactivity in male rats after single and repeated intravenous injection of 14C-bortezomib Alex Hemeryck, R Geerts, Johan Monbaliu, Cancer Chemotherapy and Pharmacology Depletion KineticsMedicineRadiation EffectPhysiologyTissue Distribution	2007	54
Novel, centrally active mGlu1 antagonists: In vitro and in vivo pharmacology Asj Lesage, François Bischoff, Ludy van Beijsterveldt, Neuropharmacology Molecular PharmacologyG Protein-coupled ReceptorMedicineFunctional SelectivityImmunology	2002	30
Effect of Efflux Inhibition on Brain Uptake of Itraconazole in Mice Infected with Cryptococcus neoformans Frédéric Imbert, Méryam Jardin, Christine Fernandez, Drug Metabolism and Disposition	2003	29
Pharmacokinetic Modeling of Non-Linear Brain Distribution of Fluvoxamine in the Rat Marian Geldof, Jan Freijer, Ludy van Beijsterveldt, Pharmaceutical Research	2007	27
Phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of HDM-2 antagonist JNJ-26854165 in patients with advanced refractory solid tumors Josep Tabernero, Luc Dirix, Patrick Schöffski, Journal of Clinical Oncology P53 Wild TypeCell DeathPathologyPharmacotherapyTumor Biology	2009	18
Mechanistic model for the acute effect of fluvoxamine on 5-HT and 5-HIAA concentrations in rat frontal cortex Marian Geldof, Jan Freijer, L. A. Peletier, European Journal of Pharmaceutical Sciences NeuropsychologyBrain FunctionNeurophysiologyMedicinePsychopharmacology	2008	13

Page 1